These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 31238899)

  • 1. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases.
    Majid S; Rydén L; Manjer J
    BMC Cancer; 2019 Jun; 19(1):626. PubMed ID: 31238899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.
    Houvenaeghel G; Boher JM; Reyal F; Cohen M; Garbay JR; Classe JM; Rouzier R; Giard S; Faure C; Charitansky H; Tunon de Lara C; Daraï E; Hudry D; Azuar P; Gimbergues P; Villet R; Sfumato P; Lambaudie E
    Eur J Cancer; 2016 Nov; 67():106-118. PubMed ID: 27640137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients.
    Majid S; Rydén L; Manjer J
    World J Surg Oncol; 2018 Mar; 16(1):54. PubMed ID: 29530065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary tumour burden in women with a fine-needle aspiration/core biopsy-proven positive node on ultrasonography compared to women with a positive sentinel node.
    Lloyd P; Theophilidou E; Newcombe RG; Pugh L; Goyal A
    Br J Surg; 2017 Dec; 104(13):1811-1815. PubMed ID: 28991362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.
    Grabau D; Dihge L; Fernö M; Ingvar C; Rydén L
    Eur J Surg Oncol; 2013 Jun; 39(6):601-7. PubMed ID: 23579175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
    Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
    Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of the extracapsular extension of the sentinel node metastasis in the surgical treatment of breast cancer].
    Maráz R; Venczel L; Sikorszki L; Ambrózay É; Serfőző O; Rajtár M; Cserni G
    Magy Seb; 2020 Mar; 73(1):16-22. PubMed ID: 32172574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan.
    Yu JC; Hsu GC; Hsieh CB; Sheu LF; Chao TY
    World J Surg; 2005 Jul; 29(7):813-8; discussion 818-9. PubMed ID: 15951935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement.
    Meretoja TJ; Strien L; Heikkilä PS; Leidenius MH
    Ann Surg Oncol; 2012 Feb; 19(2):567-76. PubMed ID: 21792511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
    Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
    Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
    Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
    Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in patients with multifocal breast cancer.
    Goyal A; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M; Sibbering M;
    Eur J Surg Oncol; 2004 Jun; 30(5):475-9. PubMed ID: 15135472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for the occurrence of four or more axillary lymph node metastases in ER-positive and HER2-negative breast cancer patients with positive sentinel node: A retrospective cohort study.
    Noda S; Onoda N; Asano Y; Kurata K; Tokumoto M; Morisaki T; Kashiwagi S; Takashima T; Hirakawa K
    Int J Surg; 2016 Feb; 26():1-5. PubMed ID: 26700202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in breast cancer New indications and our experience.
    Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
    Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.
    Osako T; Iwase T; Kimura K; Horii R; Akiyama F
    Eur J Cancer; 2013 Apr; 49(6):1187-95. PubMed ID: 23265708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.